Table of Contents Author Guidelines Submit a Manuscript
International Journal of Breast Cancer
Volume 2017, Article ID 1796145, 5 pages
https://doi.org/10.1155/2017/1796145
Research Article

Clinical Characteristics in Patients with Triple Negative Breast Cancer

1Department of Surgery, New York University Langone Medical Center, New York, NY, USA
2School of Medicine, New York University Langone Medical Center, New York, NY, USA
3Drexel University, School of Medicine, Philadelphia, PA, USA

Correspondence should be addressed to Freya Schnabel; gro.cmuyn@lebanhcs.ayerf

Received 15 February 2017; Accepted 16 July 2017; Published 17 August 2017

Academic Editor: Debra A. Tonetti

Copyright © 2017 Janet Yeh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [2 citations]

The following is the list of published articles that have cited the current article.

  • Jason H. Winnike, Delisha A. Stewart, Wimal W. Pathmasiri, Susan L. McRitchie, and Susan J. Sumner, “Stable Isotope-Resolved Metabolomic Differences between Hormone-Responsive and Triple-Negative Breast Cancer Cell Lines,” International Journal of Breast Cancer, vol. 2018, pp. 1–12, 2018. View at Publisher · View at Google Scholar
  • Gamze Guney Eskiler, Gulsah Cecener, Unal Egeli, and Berrin Tunca, “BMN 673 (talazoparib): A potent PARP inhibitor for triple negative breast cancer with different genetic profile,” Journal of Biochemical and Molecular Toxicology, pp. e22286, 2019. View at Publisher · View at Google Scholar